UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
17 min read

Smarter than AI: A Commentary on Serendipitous Drug Discovery

One in four drugs traces its origin to serendipity—unexpected discoveries that changed medicine forever. From penicillin to GLP-1s now projected to reach $100 billion by 2030, the most transformative treatments often emerge when researchers pay attention to "off-target" effects. As AI reshapes drug development, human observation and patient-centered design remain our most powerful tools for breakthrough discoveries.
Judy Lytle
Executive Director, Evidence Development Study Solutions

Posts by Date

A network of blue human figures connected by dashed lines, with one red figure prominently in the center, symbolizing a central connection.
Blog
5 min read

The Importance of Choosing the Right Pharmacovigilance Partner and Safety Physician

For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.
Middle-aged female therapists sits with a patient on the couch and comforts him, putting him at ease.
Blog
6 min read

Putting the ‘Patient’ Back in Patient Services

Putting the patient back in patient services means we do more, go deeper, and customize offerings.
Middle-aged man reviews a document with his client at a table while two other colleagues take notes.
Blog
6 min read

EMA/HMA Revised Guidance on Risk Minimization Measures

UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.
The importance of patient choice blog image
Blog
4 min read

The Importance of Patient Choice

Providing the patient with choice throughout their journey empowers them to take an active role in therapy initiation and persistence.
Woman negotiating with FDA
Blog
6 min read

Navigating Launch Readiness with FDA Negotiations

REMS readiness is a key component for certain drugs launch plans - are you on top of approval timelines and milestones and IT build needs?
Diverse Team Of Data Scientists Analyzing Information.
Blog
5 min read

ICH/FDA Draft Guidance on RWD Safety Studies Highlight Their Increased Importance

Understand the latest international opinion on the plan, design, and analysis of pharmacoepidemiological safety studies using RWD.
Concept of choice showing two arrows going different directions
Blog
9 min read

Enhance Your Pharmacovigilance and Regulatory Compliance with Expert PV System Transition Management and Seamless Migration

Whether your transition includes a vendor change, acquisition, or portfolio expansion, UBC makes it easy to transition your system.
Data overlaying a busy street corner in a downtown city
Blog
4 min read

RWD Enrichment Studies: Linking Pre- and Post-Trial Data Utilizing Tokenization

Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
Technology image depicting the cloud and connection points
Blog
5 min read

Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs

The UBC PV Tableau Data Analytics Platform provides an all-in-one dashboard system for safety Key Performance Indicators (KPIs) analysis and compliance oversight.
1 3 4 5 6 7 18

Press Inquires

UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.